-
2024 CASH | Professor LuGui Qiu : Continuous Advances in New Drugs, The Road to Cure Multiple Myeloma is Being Realized
“Oncology Frontier – Hematology Frontier“: What are the challenges and obstacles on the path to curing multiple myeloma? Professor LuGui Qiu : Multiple myeloma (MM), as one of the common malignant…
-
2024 CASH | Professor Lei Zhang : Gene Therapy Based on AAV Vector Brings Hope for Cure to Hemophilia Patients
“Oncology Frontier – Hematology Frontier“: In recent years, gene therapy mediated by adeno-associated virus (AAV) has made significant breakthroughs in the treatment of hemophilia. Could you please start by explaining the…
-
2024 CASH丨Professor Jun Shi : Gene Therapy for β-Thalassemia Using Lentiviral Vectors
From January 5th to 7th, 2024, the 4th China Hematology Development Conference (CASH) opened grandly in Tianjin. Professor Jun Shi from the Institute of Hematology of the Chinese Academy of…
-
2024 CASH | Professor Jun Ma : From ASH to CASH, the Mission of Serving Patients and Strengthening Innovation Remains Unchanged
From ASH to CASH, the Commitment to “Everything for the Patient” Remains Unchanged “Oncology Frontier – Hematology Frontier“: Professor Jun Ma, what do you think are the significant implications of domestic…
-
2024 CASH | ProfessorJianXiang Wang : Innovating Research and Standardizing Quality Control to Promote the Healthy Development of Hematology in China
Advancing the Discipline for Healthy Development “Oncology Frontier – Hematology Frontier“: With the Fourth China Hematology Development Conference (CASH) about to commence, as the perennial chairman of CASH, could you talk…
-
2024 CASH | Professor Hui Wei : Nurturing Growth in AML Treatment with Spring Breeze, Looking Forward to the Future of Immunotherapy
“Oncology Frontier – Hematology Frontier”: As the executive chair of the leukemia session at this conference, what significance do you think this meeting holds for advancing research and treatment in the…
-
2024 CASH | Professor Gang An : Continuous Innovation in CAR-T Therapy, A New Dawn in MM Treatment!
“Oncology Frontier – Hematology Frontier“: CAR-T cell therapy has been a hot topic in hematology in recent years. Could you discuss the current status of CAR-T cell therapy in the field…
-
2024 CASH | Professor ChunYan Ji : Significant Advances in Leukemia Treatment, Aiming to Achieve Treatment-Free Remission for More Patients
“Oncology Frontier – Hematology Frontier“: As the chairman of the “Leukemia” session, could you discuss the significant research advancements in the diagnosis and treatment of leukemia in recent years, especially in…
Connecting Medical Expertise through Media